By Vijay Kumar Malesu A new trial reveals that once-weekly amycretin injections help adults shed more than 20% of their body ...

Hims & Hers Health Inc.'s stock booked record losses Monday after pharmaceutical giant Novo Nordisk, maker of the weight-loss drug Wegovy, said it was ending a collaboration with the telehealth ...

For patients with IIH, sustainable weight loss offers the most effective and lasting relief from symptoms—and can help ...

Stocks jumped and oil prices tumbled Monday as Iran's retaliation for the U.S. bombing of the country's nuclear facilities resulted in no casualties or significant damage, raising hopes that the ...

Disgraced chef Paula Deen, 78, took time to reflect on her career by sharing a personal message with her social media followers. Georgia-born cooking ...

The fortune of the San Francisco-based telehealth company’s cofounder and chief executive, Andrew Dudum, crumbled by more ...

Amgen's late-stage weight-loss drug MariTide is getting ready to enter the final stages of testing as the company enrolls its ...

Skin Glow Med Spa offers services such as facials, hair removal, weight loss treatments, laser treatments and more.

Once-monthly maridebart cafraglutide resulted to significant weight loss at 1 year among adults with obesity, regardless of ...

Amycretin, a new weight-loss treatment from Novo Nordisk, combines two hunger hormones, helping participants lose nearly ...

A new clinical trial found that taking a popular diabetes and weight-loss drug once weekly significantly improves blood sugar ...

The companies engaged in an increasingly heated war of words on Monday following the drugmaker's decision to end a collaboration.